Skip to main content

RSV Medications (Respiratory Syncytial Virus)

Other names: Respiratory Syncytial Virus

Medically reviewed by Melisa Puckey, BPharm. Last updated on Feb 7, 2024.

RSV medications are RSV vaccines Abrysvo (Pfizer) and Arexvy (GSK), RSV immunizations Beyfortus (Nirsevimab) or Synagis (palivizumab), antiviral (Virazole) and treatment of symptoms.

RSV vaccines and immunizations are used to prevent severe RSV symptoms in infants and older adults who are at higher risk of hospitalization or death.

Antiviral inhalations are used to treat the viral infection in hospitalized infants and young children for severe lower respiratory tract infections.

RSV symptoms include runny nose, sore throat, stuffy nose, cough, wheezing, headache, and fever with most people recovering after 1 to 2 weeks. In very young infants, respiratory syncytial virus (RSV) symptoms may be decreased activity, irritability, and breathing difficulties. RSV symptoms can become severe in some infants and older adults and may require hospitalization.

More severe infections may cause inflammation of the small airways (bronchiolitis) and may also cause pneumonia. RSV is the most common cause of pneumonia and bronchiolitis in children under 12 months old.

The respiratory syncytial virus (RSV) is a member of the Paramyxoviridae family.

Drugs used to treat RSV

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
ribavirin Rate Add review
Rx X N
Generic name:
ribavirin systemic
Brand names:
Virazole, RibaTab
Drug class:
purine nucleosides, inhaled anti-infectives
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Synagis Rate Add review
Rx C N
Generic name:
palivizumab systemic
Drug class:
immune globulins
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Virazole Rate Add review
Rx X N
Generic name:
ribavirin systemic
Drug class:
purine nucleosides, inhaled anti-infectives
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
RibaTab Rate Add review
Rx X N
Generic name:
ribavirin systemic
Drug class:
purine nucleosides, inhaled anti-infectives
For consumers:
dosage, interactions, side effects
palivizumab Rate Add review
Rx C N
Generic name:
palivizumab systemic
Brand name:
Synagis
Drug class:
immune globulins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Arexvy Rate Add review
Rx N
Generic name:
rsv vaccine pref3, recombinant systemic
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
rsv vaccine pref3, recombinant Rate Add review
Rx N
Generic name:
rsv vaccine pref3, recombinant systemic
Brand name:
Arexvy
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
Abrysvo Rate Add review
Rx N
Generic name:
rsv vaccine, pref a-pref b, recombinant systemic
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Beyfortus Rate Add review
Rx N
Generic name:
nirsevimab systemic
Drug class:
other immunostimulants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
nirsevimab Rate Add review
Rx N
Generic name:
nirsevimab systemic
Brand name:
Beyfortus
Drug class:
other immunostimulants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
rsv vaccine, pref a-pref b, recombinant Rate Add review
Rx N
Generic name:
rsv vaccine, pref a-pref b, recombinant systemic
Brand name:
Abrysvo
Drug class:
viral vaccines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph

Frequently asked questions

View more FAQ

Topics under RSV

Learn more about RSV

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.